Genotype- or phenotype-based drug formulation

• 收藏
• 分享

专利权人:

Bayer Aktiengesellschaft

发明人:

Willmann, Stefan,Eissing, Thomas,Dickschen, Kristin

申请号：

AU2013269793

公开号：

AU2013269793B2

申请日:

2013.05.27

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The invention relates to a combination of two or more pharmaceutically active substances, of which at least one is a metabolic product ("metabolite") of the other ("parent substance"), in particular wherein the dosages thereof are selected in such a way that a genotypically or phenotypically determined variability of the conversion of the parent substance into the metabolite in certain individuals is compensated.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/